ExoToe is a medical device startup founded in 2018 that aims to revolutionize hammertoe fixation with its innovative product. The company's slogan, "Hammertoe Fixation Made Easier," reflects its mission to provide a more effective and user-friendly solution for this common foot condition. ExoToe addresses the shortcomings of existing options by introducing the first extramedullary device of its kind, which is just 0.6mm thin and preserves the bony canal. This breakthrough offers a promising alternative to the traditional methods of hammertoe fixation. The company recently secured a $997.70K investment as part of its Seed Round funding on 10 November 2022, indicating growing investor confidence in its potential. Despite not disclosing the specific investors, this financial backing signifies the promising prospects of ExoToe's innovative approach within the Health Care, Manufacturing, and Medical Devices industries. With its unique product and recent investment, ExoToe has positioned itself as an intriguing player in the evolving landscape of medical device solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $997.70K | - | 10 Nov 2022 |
No recent news or press coverage available for ExoToe.